Changes in peripheral blood Vα24⁺Vβ11⁺ NKT cells as a percentage of total T cells, and numbers of T cells in peripheral blood following administration of MoDCs. (A) Initial series of treatments with α-GalCer–pulsed MoDCs. (B-C) A second (B) and third (C) series of treatments with α-GalCer–pulsed MoDCs several months later. (D) Treatments with autologous tumor lysate–pulsed MoDCs 6 months later.